Cart
sales@molnova.com
Ufenamate
CAS No. 67330-25-0
Ufenamate( Flufenamic acid butyl ester,Butyl flufenamate )
Catalog No. M21988 CAS No. 67330-25-0
Ufenamate is an anthranilic acid-based anti-inflammatory drug developed for skin diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 36 | In Stock |
|
| 10MG | 43 | In Stock |
|
| 50MG | 56 | In Stock |
|
| 100MG | 67 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUfenamate
-
NoteResearch use only, not for human use.
-
Brief DescriptionUfenamate is an anthranilic acid-based anti-inflammatory drug developed for skin diseases.
-
DescriptionUfenamate is an anthranilic acid-based anti-inflammatory drug developed for skin diseases.
-
In Vitro——
-
In Vivo——
-
SynonymsFlufenamic acid butyl ester,Butyl flufenamate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number67330-25-0
-
Formula Weight337.34
-
Molecular FormulaC18H18F3NO2
-
Purity>98% (HPLC)
-
SolubilityDMSO:44 mg/mL (130.43 mM)
-
SMILESCCCCOC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Iino H, et al. Penetration of Ufenamate into Intact, Stripped, or Delipidized Skin Using Different Vehicles. Biol Pharm Bull. 2015;38(10):1645-8.
molnova catalog
related products
-
Mc-Val-Ala-PAB
Mc-Val-Ala-PAB, an effective linker, is utilized in antibody-drug-conjugate (ADC).
-
Lenacapavir
Lenacapavir is a potent capsid-targeting inhibitor of HIV replication. Lenacapavir shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells.
-
GS-829845
GS-829845 is a JAK1 inhibitor, the main component of the active metabolite of Filgotinib, which is approximately 10-fold less potent and has a longer half-life than the parent.
